Unknown

Dataset Information

Six-Month Survival After Extracorporeal Membrane Oxygenation for Severe COVID-19.


ABSTRACT:

Objectives

The authors evaluated the outcome of adult patients with coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS) requiring the use of extracorporeal membrane oxygenation (ECMO).

Design

Multicenter retrospective, observational study.

Setting

Ten tertiary referral university and community hospitals.

Participants

Patients with confirmed severe COVID-19-related ARDS.

Interventions

Venovenous or venoarterial ECMO.

Measurements and main results

One hundred thirty-two patients (mean age 51.1 ± 9.7 years, female 17.4%) were treated with ECMO for confirmed severe COVID-19-related ARDS. Before ECMO, the mean Sequential Organ Failure Assessment score was 10.1 ± 4.4, mean pH was 7.23 ± 0.09, and mean PaO2/f

SUBMITTER: Biancari F 

PROVIDER: S-EPMC7816613 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature